… TNFα exists both in a transmembrane and a soluble form, which… at predicting atherosclerosis
development in T2DM patients [… 1-year after ST-elevation myocardial infarction (STEMI) and …

… Cardiovascular diseases are the leading cause of death … A2 decay), isoprostanes, and
soluble NOX2-derived peptide, a … likely to undergo percutaneous coronary intervention (PCI) …

… heart diseases or increased troponin(T Guo et al., 2020). AMI (acute … with ST elevation
myocardial infarction (STEMI). This is so essentialas primary Percutaneous coronary intervention (…

… In the past decades, myocardial infarction periacute mortality … cell therapy of patients with
ischemic heart disease were not … antibody binding to both membrane-bound and soluble IL-6 …

… ST elevation myocardial infarction (STEMI). This is so essentialas primary Percutaneous
coronary intervention (… major adverse cardiac events in patients with obstructive coronary artery …

… The primary factor for coronary artery disease is myocardial … MR-pro-ANP is at least as good
at predicting mortality and heart failure … of ST-2: Soluble (ST2L) and transmembrane (ST2)[53…

… of heart failure (HF) (n=904) and myocardial infarction (MI) (n… divided into ST elevation MI
(STEMI) or non-ST elevation MI (… /or surgery such as percutaneous coronary intervention (PCI). …

… as coronary artery disease or high blood pressure cause heart … Serum soluble ST2 is a novel
biomarker for neurohormonal … detect MI following percutaneous coronary intervention (PCI). …

… landscape for acute ischaemic heart disease, with a focus on … thrombolysis and percutaneous
coronary intervention (PCI) … diverse diseases, new computational capabilities for predicting …

… have been shown to predict cardiovascular diseases. Furthermore, … effect is the inhibition of
soluble TNF-α shedding and its … of recurrent CV events in the group of high-risk patients. On …